OOIR: Observatory of International Research

Papers

(The H4-Index of JHEP Reports is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Increased carbohydrate deficient transferrin: Whisky or candy?	154
Reply to: “Hepatic bile acid transport increases in the postprandial state: A functional 11C-CSar PET/CT study in healthy humans”	148
Copyright and information	118
The Weight of Choices: Prioritizing Lifestyle Over GLP-1 Receptor Agonist Therapy in Managing MASLD	116
JMJD2D stabilises and cooperates with HBx protein to promote HBV transcription and replication	106
Combined inhibition of bile salt synthesis and intestinal uptake reduces cholestatic liver damage and colonic bile salts in mice	104
Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites”	104
External validation of the IAIHG autoimmune hepatitis response criteria in a multicentric real-world cohort	102
Hepatitis C virus replication requires integrity of mitochondria-associated ER membranes	94
Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer	73
Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosis	69
Predicting liver ablation volumes with real-time MRI thermometry	68
Copyright and information	63
Induction of phospholipase A2 group 4C by HCV infection regulates lipid droplet formation	57
Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort st	55
Liver stiffness measurement predicts clinical outcomes in autoimmune hepatitis	55
Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis	53
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool	48
Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis	48
What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association	47
Emerging roles of circular RNAs in liver cancer	47
Protective role of physical activity against HCC risk in type 2 diabetes: Evidence and public health perspectives	47
Erratum to “Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis” [JHEP Reports 6 (2024) 100949]	46
Reply to: “Dynamic imaging of macrophages in MASLD: A major interest in insulin resistance and outside the liver”	46
Identifying emergency presentations of chronic liver disease using routinely collected administrative hospital data	46

Epigenetics of alcohol-related liver diseases	44
Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis	44
A small animal model of chronic hepatitis E infection using immunocompromised rats	42
Changing epidemiology of hepatocellular carcinoma in the Mediterranean area: a challenge for surveillance?	41
HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates	40
Metabolomics biomarkers of hepatocellular carcinoma in a prospective cohort of patients with cirrhosis	40
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment	40
Editorial Board page	39
Copyright and information	39
Xanthine oxidase promotes hepatic lipid accumulation through high fat absorption by the small intestine	38
Ablation of liver Fxr results in an increased colonic mucus barrier in mice	38
Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency	38
SARS-CoV-2 receptor ACE2 is upregulated by fatty acids in human MASH	38